Clinical Study of STI Screening to Prevent Adverse Birth and New-born Outcomes
Conditions: Sexually Transmitted Infection; HIV/AIDS; Cost-effectiveness; Birth Outcomes; Vaginal Microbiome; Neisseria Gonorrhoeae; Chlamydia Trachomatis; Trichomonas Vaginalis; Antenatal Care; Pregnancy Interventions: Diagnostic Test: First antenatal care + test-of-cure; Diagnostic Test: First antenatal care + week 30-34 gestation (no test-of-cure) Sponsors: Foundation for Professional Development (Pty) Ltd; University of California, Los Angeles; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID); University of Cape Town; University of Alabama at Birmingham; Louisi ana State University Health Sciences Center in New Orleans Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | HIV AIDS | Infectious Diseases | Pregnancy | Research | Study